InsidersTradesSigma
Total declarations
Company
▲ Purchases (17 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
17
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-51.9%
Across 17 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Aquilo Capital Management, LLC. Officer active across 1 company, notably Spero Therapeutics, Inc.. In total, 18 filings have been recorded. Breakdown: 17 buys · 1 sell. Total volume traded: €16.2m. Activity tracked since 20 August 2021. The latest transaction was disclosed on 22 September 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Aquilo Capital Management, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
1,335,512 shares@ US$2.250310.7% of flowCommon Stock, $0.001 par valueSEC:0001591986-22-000018:0
39,727 shares@ US$5.2351.2% of flowCommon Stock, $0.001 par valueSEC:0001591986-22-000015:0
Canonical exit: 25 Jul 2022 (T+90)
33,115 shares@ US$8.78841.6% of flowCommon Stock, $0.001 par valueSEC:0001591986-22-000014:0
Canonical exit: 28 Jun 2022 (T+90)
15,702 shares@ US$7.6260.7% of flowCommon Stock, $0.001 par valueSEC:0001591986-22-000013:0
Canonical exit: 12 Jun 2022 (T+90)
29,729 shares@ US$9.52931.6% of flowCommon Stock, $0.001 par valueSEC:0001591986-22-000011:0
Canonical exit: 29 May 2022 (T+90)
14,828 shares@ US$9.24190.7% of flowCommon Stock, $0.001 par valueSEC:0001591986-22-000010:0
Canonical exit: 19 May 2022 (T+90)
125,000 shares@ US$11.58618.0% of flowCommon Stock, $0.001 par valueSEC:0001591986-22-000004:0
Canonical exit: 1 May 2022 (T+90)
1,599 shares@ US$10.89310.1% of flowCommon Stock, $0.001 par valueSEC:0001591986-22-000003:0
Canonical exit: 24 Apr 2022 (T+90)
48,488 shares@ US$12.41473.3% of flowCommon Stock, $0.001 par valueSEC:0001591986-22-000002:0
Canonical exit: 18 Apr 2022 (T+90)
8,867 shares@ US$12.92530.6% of flowCommon Stock, $0.001 par valueSEC:0001591986-22-000001:0
Canonical exit: 10 Apr 2022 (T+90)
75,493 shares@ US$14.64066.0% of flowCommon Stock, $0.001 par valueSEC:0001691902-22-000001:0
Canonical exit: 29 Mar 2022 (T+90)
150,000 shares@ US$17.534513.9% of flowCommon Stock, $0.001 par valueSEC:0001591986-21-000016:0
Canonical exit: 27 Jan 2022 (T+90)
134,543 shares@ US$18.649613.4% of flowCommon Stock, $0.001 par valueSEC:0001591986-21-000015:0
Canonical exit: 29 Dec 2021 (T+90)
44,210 shares@ US$18.56314.3% of flowCommon Stock, $0.001 par valueSEC:0001591986-21-000014:0
Canonical exit: 12 Dec 2021 (T+90)
24,749 shares@ US$18.49742.4% of flowCommon Stock, $0.001 par valueSEC:0001591986-21-000013:0
Canonical exit: 8 Dec 2021 (T+90)
44,042 shares@ US$17.86614.1% of flowCommon Stock, $0.001 par valueSEC:0001591986-21-000012:0
Canonical exit: 28 Nov 2021 (T+90)
22,982 shares@ US$16.54872.0% of flowCommon Stock, $0.001 par valueSEC:0001591986-21-000011:0
Canonical exit: 24 Nov 2021 (T+90)
221,190 shares@ US$14.860117.4% of flowCommon Stock, $0.001 par valueSEC:0001591986-21-000010:0
Canonical exit: 18 Nov 2021 (T+90)
18 of 18 declarations
About Aquilo Capital Management, LLC
Aquilo Capital Management, LLC is a declarant with 18 filings in total. The sampled recent filings, all related to Spero Therapeutics, Inc. on XNAS, span from 2021-08-24 to 2022-09-26, with buys of EUR 13165261 and sells of EUR 3053688, and the modal transaction nature indicated is Acquisition.
